Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels
Nov 01 2024
•
By
Bridget Silverman
The FDA's November calendar includes user fee goal dates for six novel agents.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fee Goal Dates
More from United States